Filed: 8/14/2026ACC: 0001104659-26-097133
📋 What this filing means
FORESITE CAPITAL MANAGEMENT VI LLC filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $642.58M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$642.58M
Total AUM (reported)
27.33M
Total Shares
Allocation by class
COM$593.14M92.3%
ORD$25.28M3.9%
CL A$24.16M3.8%
Portfolio Concentration
Top 3$326.54M50.8%
4–10$197.48M30.7%
11–25$118.56M18.5%
Top 3 weight
50.8%
Top 10 weight
81.5%
Voting Authority Distribution
Total shares with voting rights: 27.33M
Sole
Full voting authority
27.33M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
CG Oncology, Inc.
SOLEShares2.37M
TypeSH
Market value$168.36M
26.20%
Sole
2.37M
Shared
0.00
None
0.00
ALUMIS INC.
SOLEShares4.25M
TypeSH
Market value$119.53M
18.60%
Sole
4.25M
Shared
0.00
None
0.00
Seaport Therapeutics, Inc.
SOLEShares1.78M
TypeSH
Market value$38.65M
6.02%
Sole
1.78M
Shared
0.00
None
0.00
Denali Therapeutics Inc.
SOLEShares1.40M
TypeSH
Market value$35.92M
5.59%
Sole
1.40M
Shared
0.00
None
0.00
Celldex Therapeutics, Inc.
SOLEShares879.71K
TypeSH
Market value$32.73M
5.09%
Sole
879.71K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS, INC.
SOLEShares785K
TypeSH
Market value$29.13M
4.53%
Sole
785K
Shared
0.00
None
0.00
Corvus Pharmaceuticals, Inc.
SOLEShares1.83M
TypeSH
Market value$27.36M
4.26%
Sole
1.83M
Shared
0.00
None
0.00
Parabilis Medicines, Inc.
SOLEShares999.04K
TypeSH
Market value$27.34M
4.26%
Sole
999.04K
Shared
0.00
None
0.00
GH Research PLC
SOLEShares940.49K
TypeSH
Market value$25.28M
3.93%
Sole
940.49K
Shared
0.00
None
0.00
Jade Biosciences, Inc.
SOLEShares886.67K
TypeSH
Market value$19.70M
3.07%
Sole
886.67K
Shared
0.00
None
0.00
Hinge Health, Inc.
SOLEShares220.40K
TypeSH
Market value$18.29M
2.85%
Sole
220.40K
Shared
0.00
None
0.00
Kymera Therapeutics, Inc.
SOLEShares146.33K
TypeSH
Market value$16.78M
2.61%
Sole
146.33K
Shared
0.00
None
0.00
AtaiBeckley Inc.
SOLEShares2.75M
TypeSH
Market value$14.49M
2.26%
Sole
2.75M
Shared
0.00
None
0.00
Verastem, Inc.
SOLEShares3.15M
TypeSH
Market value$12.02M
1.87%
Sole
3.15M
Shared
0.00
None
0.00
Beam Therapeutics Inc.
SOLEShares330K
TypeSH
Market value$11.33M
1.76%
Sole
330K
Shared
0.00
None
0.00
Minerva Neurosciences, Inc.
SOLEShares1.99M
TypeSH
Market value$11.02M
1.71%
Sole
1.99M
Shared
0.00
None
0.00
ArriVent BioPharma, Inc.
SOLEShares301.34K
TypeSH
Market value$10.47M
1.63%
Sole
301.34K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares1.33M
TypeSH
Market value$9.47M
1.47%
Sole
1.33M
Shared
0.00
None
0.00
Crinetics Pharmaceuticals, Inc.
SOLEShares212.01K
TypeSH
Market value$7.93M
1.23%
Sole
212.01K
Shared
0.00
None
0.00
Research Alliance Corp III
SOLEShares300K
TypeSH
Market value$3.21M
0.50%
Sole
300K
Shared
0.00
None
0.00
Zura Bio Ltd
SOLEShares450K
TypeSH
Market value$2.65M
0.41%
Sole
450K
Shared
0.00
None
0.00
Kailera Therapeutics, Inc.
SOLEShares37.50K
TypeSH
Market value$826.1K
0.13%
Sole
37.50K
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares970.00
TypeSH
Market value$70.9K
0.01%
Sole
970.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG Oncology, Inc.SOLE | COM | 2.37M | SH | $168.36M 26.20% | 2.37M | 0.00 | 0.00 |
ALUMIS INC.SOLE | COM | 4.25M | SH | $119.53M 18.60% | 4.25M | 0.00 | 0.00 |
Seaport Therapeutics, Inc.SOLE | COM | 1.78M | SH | $38.65M 6.02% | 1.78M | 0.00 | 0.00 |
Denali Therapeutics Inc.SOLE | COM | 1.40M | SH | $35.92M 5.59% | 1.40M | 0.00 | 0.00 |
Celldex Therapeutics, Inc.SOLE | COM | 879.71K | SH | $32.73M 5.09% | 879.71K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS, INC.SOLE | COM | 785K | SH | $29.13M 4.53% | 785K | 0.00 | 0.00 |
Corvus Pharmaceuticals, Inc.SOLE | COM | 1.83M | SH | $27.36M 4.26% | 1.83M | 0.00 | 0.00 |
Parabilis Medicines, Inc.SOLE | COM | 999.04K | SH | $27.34M 4.26% | 999.04K | 0.00 | 0.00 |
GH Research PLCSOLE | ORD | 940.49K | SH | $25.28M 3.93% | 940.49K | 0.00 | 0.00 |
Jade Biosciences, Inc.SOLE | COM | 886.67K | SH | $19.70M 3.07% | 886.67K | 0.00 | 0.00 |
Hinge Health, Inc.SOLE | CL A | 220.40K | SH | $18.29M 2.85% | 220.40K | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | COM | 146.33K | SH | $16.78M 2.61% | 146.33K | 0.00 | 0.00 |
AtaiBeckley Inc.SOLE | COM | 2.75M | SH | $14.49M 2.26% | 2.75M | 0.00 | 0.00 |
Verastem, Inc.SOLE | COM | 3.15M | SH | $12.02M 1.87% | 3.15M | 0.00 | 0.00 |
Beam Therapeutics Inc.SOLE | COM | 330K | SH | $11.33M 1.76% | 330K | 0.00 | 0.00 |
Minerva Neurosciences, Inc.SOLE | COM | 1.99M | SH | $11.02M 1.71% | 1.99M | 0.00 | 0.00 |
ArriVent BioPharma, Inc.SOLE | COM | 301.34K | SH | $10.47M 1.63% | 301.34K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 1.33M | SH | $9.47M 1.47% | 1.33M | 0.00 | 0.00 |
Crinetics Pharmaceuticals, Inc.SOLE | COM | 212.01K | SH | $7.93M 1.23% | 212.01K | 0.00 | 0.00 |
Research Alliance Corp IIISOLE | CL A | 300K | SH | $3.21M 0.50% | 300K | 0.00 | 0.00 |
Zura Bio LtdSOLE | CL A | 450K | SH | $2.65M 0.41% | 450K | 0.00 | 0.00 |
Kailera Therapeutics, Inc.SOLE | COM | 37.50K | SH | $826.1K 0.13% | 37.50K | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | COM | 970.00 | SH | $70.9K 0.01% | 970.00 | 0.00 | 0.00 |